Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

Elon Musk achieved a massive weight loss transformation, and he wasn't shy about how he did it. Before we get into how he ...

Four years after starting semaglutide, patients maintained an average weight loss of 10% of their body weight, a peer-reviewed 2024 study funded by Novo Nordisk found. Doctors say the drug’s ...

Nausea is the most common side effect of semaglutide, the weight loss and diabetes medication often sold under the brand names Ozempic and Wegovy. It is particularly common after starting the ...

Are you wondering whether you’re a candidate for one of the newer weight-loss drugs, semaglutide (Wegovy) and tirzepatide (Zepbound)? These injectables are approved specifically for weight loss ...

Kathy Bates, Oprah, Ashley Benson and more celebs who've talked about semaglutide drugs including ... have become popular in Hollywood for weight loss both for those who only need to lose a ...

Findings showed tirzepatide was superior to semaglutide for both the primary endpoint and all key secondary endpoints at 72 weeks. Average weight loss in the tirzepatide group was 20.2% compared ...